Enlivex Therapeutics Ltd (ENLV)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.82M
Last updated: Nov 17, 2026 at 11:04 AM ET
Enlivex Therapeutics Ltd (ENLV) Earnings: Report Dates and Results
Enlivex Therapeutics (ENLV) is expected to report earnings on Mar 23, 2027. In the quarter ended Jun 30, 2026, Enlivex Therapeutics reported EPS of -$1.20, below the -$0.31 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ENLV has an expected report date of Mar 23, 2027.
Earnings History
Of the 30 quarters below that had an estimate, ENLV beat 16, missed 12 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 650.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$1.20 | -$0.31 | -$0.31 - -$0.31 | -287.10% | Miss | N/A | 1 | 0 up, 1 down | Sep 4, 2026 |
| Mar 31, 2026 | -$0.15 | -$0.02 | N/A | -650.00% | Miss | N/A | 1 | 0 up, 1 down | Jun 26, 2026 |
| Dec 31, 2025 | -$1.41 | -$0.45 | -$0.45 - -$0.45 | -213.33% | Miss | N/A | 1 | 1 up, 0 down | Mar 25, 2026 |
| Sep 30, 2025 | -$1.35 | -$1.80 | -$1.80 - -$1.80 | +25.00% | Beat | N/A | 1 | 1 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$1.20 | -$2.40 | -$2.40 - -$2.40 | +50.00% | Beat | N/A | 1 | 0 up, 1 down | Aug 29, 2025 |
| Mar 31, 2025 | -$2.25 | -$2.40 | -$2.40 - -$2.40 | +6.25% | Beat | N/A | 1 | 0 up, 1 down | May 30, 2025 |
| Dec 31, 2024 | -$0.23 | -$0.16 | -$0.16 - -$0.16 | -43.75% | Miss | N/A | 1 | 1 up, 0 down | Feb 26, 2025 |
| Sep 30, 2024 | -$1.80 | -$2.40 | -$2.40 - -$2.40 | +25.00% | Beat | N/A | 1 | 1 up, 0 down | Nov 29, 2024 |
| Jun 30, 2024 | -$2.40 | -$1.20 | N/A | -100.00% | Miss | N/A | 1 | 0 up, 0 down | Aug 30, 2024 |
| Mar 31, 2024 | -$3.30 | -$3.75 | -$3.75 - -$3.75 | +12.00% | Beat | N/A | 1 | 0 up, 0 down | Jun 14, 2024 |
| Dec 31, 2023 | -$7.20 | -$4.20 | N/A | -71.43% | Miss | N/A | N/A | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | -$4.80 | -$4.80 | -$4.80 - -$4.80 | 0.00% | In line | N/A | 1 | 1 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$0.40 | -$0.46 | -$0.46 - -$0.46 | +13.04% | Beat | N/A | 1 | 0 up, 0 down | Sep 1, 2023 |
| Mar 31, 2023 | -$5.85 | -$6.00 | -$6.00 - -$6.00 | +2.50% | Beat | N/A | 1 | 0 up, 0 down | Apr 4, 2023 |
| Dec 31, 2022 | -$5.85 | -$5.70 | -$5.70 - -$5.70 | -2.63% | Miss | N/A | 1 | 0 up, 0 down | Mar 31, 2023 |
| Sep 30, 2022 | -$4.65 | -$4.35 | -$4.35 - -$4.35 | -6.90% | Miss | N/A | 1 | 0 up, 0 down | Dec 5, 2022 |
| Jun 30, 2022 | -$8.10 | -$6.75 | N/A | -20.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 22, 2022 |
| Mar 31, 2022 | -$6.75 | -$6.15 | -$6.15 - -$6.15 | -9.76% | Miss | N/A | 1 | 0 up, 0 down | Apr 29, 2022 |
| Sep 30, 2021 | -$2.85 | -$3.15 | -$3.15 - -$3.15 | +9.52% | Beat | N/A | 1 | N/A | Nov 22, 2021 |
| Jun 30, 2021 | -$2.55 | -$3.90 | -$3.90 - -$3.90 | +34.62% | Beat | N/A | 1 | N/A | Aug 9, 2021 |
| Mar 31, 2021 | -$2.85 | -$3.15 | N/A | +9.52% | Beat | N/A | 1 | N/A | Apr 30, 2021 |
| Dec 31, 2020 | -$0.25 | -$0.24 | N/A | -4.17% | Miss | N/A | 1 | N/A | Feb 26, 2021 |
| Sep 30, 2020 | -$2.40 | -$2.70 | -$2.70 - -$2.70 | +11.11% | Beat | N/A | 1 | N/A | Oct 30, 2020 |
| Jun 30, 2020 | -$3.45 | -$3.60 | -$3.60 - -$3.60 | +4.17% | Beat | N/A | 1 | N/A | Aug 14, 2020 |
| Mar 31, 2020 | -$1.05 | -$3.60 | -$3.60 - -$3.60 | +70.83% | Beat | N/A | 1 | N/A | Apr 30, 2020 |
| Dec 31, 2019 | -$0.25 | -$0.25 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 21, 2020 |
| Sep 30, 2019 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 26, 2019 |
| Mar 31, 2019 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2019 |
| Dec 31, 2018 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2019 |
| Sep 30, 2018 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2018 |
| Jun 30, 2018 | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 26, 2018 |
| Mar 31, 2018 | -$2.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 6, 2018 |
| Dec 31, 2017 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 23, 2018 |
| Sep 30, 2017 | -$2.56 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 2, 2017 |
| Jun 30, 2017 | -$4.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 4, 2017 |
| Mar 31, 2017 | -$6.40 | -$11.60 | N/A | +44.83% | Beat | N/A | N/A | N/A | May 26, 2017 |
| Dec 31, 2016 | -$7.60 | -$10.80 | N/A | +29.63% | Beat | N/A | N/A | N/A | Feb 24, 2017 |
| Sep 30, 2016 | -$11.20 | -$8.80 | N/A | -27.27% | Miss | N/A | N/A | N/A | Nov 29, 2016 |
| Jun 30, 2016 | -$8.80 | -$10.80 | N/A | +18.52% | Beat | N/A | N/A | N/A | Aug 25, 2016 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$6.21, after -$7.73 the year before. It was -$42.40 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$6.21 | N/A |
| Dec 31, 2024 | -$7.73 | N/A |
| Dec 31, 2023 | -$18.25 | N/A |
| Dec 31, 2022 | -$33.60 | N/A |
| Dec 31, 2020 | -$7.15 | N/A |
| Dec 31, 2019 | -$0.81 | N/A |
| Dec 31, 2018 | -$3.12 | N/A |
| Dec 31, 2017 | -$13.12 | N/A |
| Dec 31, 2016 | -$40.40 | N/A |
| Dec 31, 2015 | -$42.40 | N/A |
Frequently Asked Questions About ENLV
When is Enlivex Therapeutics's next earnings date?
Enlivex Therapeutics's next earnings report is expected for Mar 23, 2027.
Did ENLV beat earnings estimates last quarter?
No. Enlivex Therapeutics reported EPS of -$1.20 for the quarter ended Jun 30, 2026, below the -$0.31 estimate by 287.10%.
What EPS do analysts expect from ENLV next quarter?
The consensus EPS estimate for Enlivex Therapeutics for the quarter ending Dec 31, 2026 is -$4.24 from 3 analysts.
How often does ENLV beat earnings estimates?
Enlivex Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -135.99%.
ENLV pages: Overview, Earnings, Forecast, Financials, Competitors